Global private equity and venture capital news and research

Posts Tagged ‘Janus Capital Management’

21 May 2015

Vivo Capital, Venrock help gene therapy business Regenxbio to weighty $70.5m Series D

microscope pic Gene therapy-focused biotech business Regenxbio has closed a hefty $70.5m Series D financing round thanks to investment from firms including Vivo Capital and Venrock.

9 January 2015

OrbiMed, Janus join $51.4m Series D for cancer-fighting Aduro Biotech

syringe-m Venture capital investors Orbimed and Janus Capital Management are among new investors backing a hefty $51.4m Series D round of financing for cancer-researching biotech company Aduro Biotech.

22 April 2014

Vivo Capital leads $58.5m Series D for ProNAi Therapeutics

biotech_lrg Nucleic acid therapeutics developer ProNAi Therapeutics has secured $59.5m in a Series D round led by venture capital firm Vivo Capital.

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015